Schaefer L, Hausser H, Altenburger M, Ugorcakova J, August C, Fisher L W, Schaefer R M, Kresse H
Department of Internal Medicine, Department of Physiological Chemistry, Münster, Germany.
Kidney Int. 1998 Nov;54(5):1529-41. doi: 10.1046/j.1523-1755.1998.00149.x.
Among the small proteoglycans, biglycan and decorin have been proposed to be potent modulators of TGF-beta-mediated inflammatory kidney diseases. They were considered to become induced during glomerulonephritis and to subsequently inactivate the cytokine.
Decorin and biglycan as well as their endocytosis receptor were investigated in normal rat renal cortex, in anti-Thy-1 glomerulonephritis, in polycystic kidneys, in the remnant kidney following 5/6-nephrectomy, and in kidneys from the Milan normotensive strain by immunohistochemistry and in situ hybridization. Northern blots were used for the detection of mRNA expression for decorin and biglycan in isolated glomeruli. Functional aspects of the endocytosis of decorin and biglycan were studied in cultured mesangial cells.
In the normal adult rat kidney decorin was expressed preferentially by Bowman's capsule and by interstitial connective tissue cells, but only in trace amounts by mesangial cells. In contrast, biglycan was found in tubular epithelial cells, in association with glomerular capillaries, podocytes and occasionally in the mesangium. In the tubulointerstitium of diseased kidneys (polycystic kidneys, 5/6-nephrectomy, kidneys from the Milan normotensive strain) there was a general up-regulation of decorin expression, while biglycan was localized only in distinct foci of fibrotic lesions. Glomerulosclerosis (5/6-nephrectomy, Milan normotensive strain) was associated with an increased staining for both decorin and biglycan within glomeruli. However, even in the anti-Thy-1 model of an acute mesangioproliferative glomerulonephritis where the greatest accumulation of decorin was found there was only a slight enhancement of decorin mRNA in isolated glomeruli. Decorin and biglycan become degraded upon receptor-mediated endocytosis. Immunohistochemical investigations indicated that the pattern of expression of the receptor protein correlated well with the immunolocalization of both decorin and biglycan. In vitro experiments with cultured mesangial cells provided direct evidence for the expression of the receptor and for the cell's capability to endocytose decorin as well as biglycan.
Decorin and biglycan are characterized by a distinct expression pattern in the normal rat kidney, whereas the presence of their endocytosis receptor protein correlates with the expression of both proteoglycans. Decorin is almost completely absent in the normal mesangium. Both proteoglycans become up-regulated in various models of renal disease. The mesangial accumulation of decorin in the anti-Thy-1 glomerulonephritis that is observed in spite of the only slightly enhanced mRNA expression could result from decreased decorin turnover and/or increased mesangial retention.
在小蛋白聚糖中,双糖链蛋白聚糖和核心蛋白聚糖被认为是转化生长因子-β介导的炎症性肾脏疾病的有效调节因子。它们被认为在肾小球肾炎期间被诱导产生,随后使细胞因子失活。
通过免疫组织化学和原位杂交技术,在正常大鼠肾皮质、抗 Thy-1 肾小球肾炎、多囊肾、5/6 肾切除后的残余肾以及米兰正常血压大鼠的肾脏中,研究核心蛋白聚糖、双糖链蛋白聚糖及其内吞受体。使用 Northern 印迹法检测分离肾小球中核心蛋白聚糖和双糖链蛋白聚糖的 mRNA 表达。在培养的系膜细胞中研究核心蛋白聚糖和双糖链蛋白聚糖内吞的功能方面。
在正常成年大鼠肾脏中,核心蛋白聚糖主要由鲍曼囊和间质结缔组织细胞表达,但系膜细胞中仅微量表达。相比之下,双糖链蛋白聚糖存在于肾小管上皮细胞中,与肾小球毛细血管、足细胞相关,偶尔也存在于系膜中。在患病肾脏(多囊肾、5/6 肾切除、米兰正常血压大鼠的肾脏)的肾小管间质中,核心蛋白聚糖的表达普遍上调,而双糖链蛋白聚糖仅定位于纤维化病变的特定区域。肾小球硬化(5/6 肾切除、米兰正常血压大鼠)与肾小球内核心蛋白聚糖和双糖链蛋白聚糖的染色增加有关。然而,即使在急性系膜增生性肾小球肾炎的抗 Thy-1 模型中,尽管发现核心蛋白聚糖积累最多,但分离肾小球中核心蛋白聚糖 mRNA 仅略有增强。核心蛋白聚糖和双糖链蛋白聚糖在受体介导的内吞作用下会降解。免疫组织化学研究表明,受体蛋白的表达模式与核心蛋白聚糖和双糖链蛋白聚糖的免疫定位密切相关。对培养的系膜细胞进行的体外实验为受体的表达以及细胞内吞核心蛋白聚糖和双糖链蛋白聚糖的能力提供了直接证据。
核心蛋白聚糖和双糖链蛋白聚糖在正常大鼠肾脏中具有独特的表达模式,而它们的内吞受体蛋白的存在与这两种蛋白聚糖的表达相关。正常系膜中几乎完全不存在核心蛋白聚糖。在各种肾脏疾病模型中,这两种蛋白聚糖均上调。在抗 Thy-1 肾小球肾炎中观察到的核心蛋白聚糖在系膜中的积累,尽管 mRNA 表达仅略有增强,但可能是由于核心蛋白聚糖周转减少和/或系膜滞留增加所致。